Researchers have identified a single mutation in the MDS3 gene that improves yeast's tolerance to carbon dioxide pressure, resulting in full-flavored beer. This breakthrough could lead to improved quality beer production worldwide.
Researchers developed a highly effective and safe Zika vaccine technology that prevents systemic infection in pregnant mice and stimulates an immunogenic reaction. The vaccine was tested in various mouse models, proving safe and protective against the virus.
A diet rich in guar gum fibre has been shown to limit inflammation and delay the onset of multiple sclerosis (MS) symptoms in mice. The study found that only guar gum significantly reduced MS-like symptoms, suggesting its potential as a therapeutic approach for humans.
Researchers sequenced giant viruses in the unique freshwater lake, finding a diverse community with distinct genetic repertoires. The study highlights the importance of viruses in biomass turnover and ecosystem balance, particularly in high Arctic environments.
A new study published in Applied and Environmental Microbiology suggests that oil formulations with food-grade organic acids can kill dried Salmonella on stainless steel surfaces. This approach has the potential to replace water-based cleaning methods, which promote microbial growth and are often challenging to use.
The new phage T4-COVID-19 vaccine elicits superior mucosal immunity in mice, inducing robust humoral and cell-mediated immune responses. The vaccine provides complete protection against SARS-CoV-2 variants with minimal lung lesions and no impact on gut microbiota.
A new methodology predicts soil recovery after wildfires by analyzing the impact of microbes and nutrients on soil regeneration. The study found that including uncommon soil microbiota was critical to predicting water quality and terrestrial ecosystem recovery.
New research found that coinfection with influenza A virus can significantly suppress SARS-CoV-2 replication in the lung. This effect can persist even after clearance of influenza A virus, suggesting potential factors that restrict SARS-CoV-2 growth.
Researchers found that SARS-CoV-2 surrogates can survive on meat products in the refrigerator or freezer for up to 30 days. The study used chicken, beef, pork, and salmon, as well as viruses with spikes similar to those on SARS-CoV-2.
A polio outbreak risk has been heightened in western Ukraine due to the reintroduction of wild-type poliovirus and low immunization rates. The situation has worsened with the COVID-19 pandemic, ongoing war, and healthcare reforms, leading to a public health emergency declaration.
Researchers developed e-bandages producing hydrogen peroxide to treat wound infections, reducing MRSA biofilm bacteria by 99 percent. This alternative method to antibiotics has the potential to improve wound healing and reduce antibiotic resistance.
Researchers evaluate Jumpcode Genomics CRISPRclean technology for transforming pandemic response through highly sensitive testing. The assay quickly identifies variant strain types and individual host responses in a single workflow.
Researchers discovered over 1,200 RNA viruses linked to carbon absorption on the ocean floor. The study suggests engineered viruses could be used as 'knobs' to control carbon storage, potentially slowing climate change.
A new study analyzing 8 cohorts of COVID-19 patients found that antibody responses in previously infected individuals were relatively stable, providing protection from reinfection unless the new infection was the Omicron variant. Vaccination also boosted protection, with rapid immune responses observed even after a single vaccine dose.
Seagrasses release massive amounts of sugar into their soils, storing up to 35 times more carbon than forests. Microbes thrive on the sucrose despite phenolics inhibiting metabolism, and beneficial relationships between plants and rhizosphere microorganisms are found.
Researchers tracked COVID-19 infection dynamics in adults over time, using repeated sampling and different testing methodologies. The study revealed factors influencing infection course and transmission risk, including viral genome loads and shedding times.
The new report highlights the pivotal impact of microbes on climate change, with major drivers being producers and consumers of greenhouse gases. The report provides recommendations for researchers, policymakers, and regulators to harness the power of microbes in tackling climate change.
Researchers from King's College London and Guy's and St Thomas' NHS Foundation Trust studied nine immunocompromised patients with persistent COVID-19 infections, finding that five developed at least one mutation seen in variants of concern. The study provides evidence that new variants may develop in immunocompromised individuals.
A Spanish study found that adults hospitalised with COVID-19 were three times as likely to die within 30 days and 90 days compared to those hospitalised for seasonal influenza. The study also revealed that COVID-19 patients spent more time in the hospital, ICU, and required more expensive treatment.
A longer interval between COVID-19 vaccine doses can significantly increase antibody production in naive individuals, with effects observed in younger participants. However, the impact of dosing interval on antibody levels in those with previous infection is minimal.
Researchers discovered MRSA in 10% of hedgehogs in Helsinki, including a successful clone with global spread potential. The study suggests spillover of antimicrobial resistance from anthropogenic sources to urban wildlife, posing a risk for human patients.
A US study found that almost three-quarters of antibiotics prescribed to patients over 65 are inappropriate, and two-thirds for Black patients. The study also showed that Hispanic/LatinX patients receive over half of their antibiotics inappropriately.
Outpatient antibiotic prescribing in Australia decreased significantly during the pandemic, with a 38% drop in winter 2020 compared to pre-pandemic years. The reduction was predominantly due to decreases in GP prescribing and targeted public education efforts.
A 31-year-old woman, a healthcare worker, tested positive for the Omicron strain of SARS-CoV-2 just 20 days after having a Delta infection. The 20-day gap between infections is the shortest known. Fully vaccinated and boosted, she developed symptoms without immunity.
A global study found that COVID-19 deaths increased by an average of 449 more over the weekend compared to weekdays, with the USA, Brazil, and UK experiencing significantly higher increases. The study suggests bureaucratic delays, hospital staffing levels, and organizational factors contribute to the phenomenon.
A new study reveals that a specific bacterium breaks down xanthan gum in the human gut, leading to the production of short-chain fatty acids. The widespread consumption of xanthan gum may alter the gut microbiome, potentially affecting intestinal health and total caloric intake.
A study of nearly a million adults in England found that those at risk of heart attack or stroke over the next 10 years are substantially more likely to become seriously unwell with COVID-19. People with elevated cardiovascular risk were six times as likely to die from COVID-19 and had three times the risk of hospitalization, according...
An international team of researchers has identified 5,500 new RNA virus species that represent all five known RNA virus phyla. The study suggests there are at least five new RNA virus phyla needed to capture them and highlights the importance of marine microbes in ocean adaptation to climate change.
A systematic review of 35 observational studies found that current immunisation coverage target of 95% may only be the minimum requirement for elimination. The analysis estimated average MCV2 vaccine effectiveness was 96.4%, indicating that a vaccination level of 95% should be considered a minimum requirement, not a goal.
Researchers found that healthy companion animals and their owners can transmit antibiotic-resistant bacteria and genes to each other, highlighting the importance of hygiene practices around pets. The study suggests that even low-level shedding of bacteria by healthy carriers can pose a risk to vulnerable individuals.
An analysis of patient-reported data on molnupiravir suggests improved outcomes for most COVID-related symptoms, including loss of smell and fatigue. The drug also showed reduced symptom progression in non-hospitalized patients with high-risk conditions.
New data from the MOVe-OUT trial reveals that molnupiravir significantly reduces SARS-CoV-2 infection within three days of treatment. In contrast, those receiving a placebo took up to five days to clear the virus. The study confirms molnupiravir's effectiveness in accelerating viral RNA decline and eliminating infectious virus.
A new analysis of data on molnupiravir shows the drug effectively clears active SARS-CoV-2 virus in both immunocompromised and non-immunocompromised patients. The study found similar reductions in viral replication and no infectious virus detected after treatment, indicating equal efficacy in both groups.
A French study suggests that long-term use of protease inhibitors may lower the risk of COVID-19 infection by 70%. The study found that patients taking PIs had a lower incidence of COVID-19 compared to those not on PIs, despite having similar risk factors.
Researchers found that patients infected with the Alpha variant experienced different neurological and emotional symptoms compared to those infected with the original form of SARS-CoV-2. The study suggests that different COVID-19 variants may give rise to distinct long COVID symptoms.
The omicron variant's infectiousness period is uncertain, with evidence suggesting it may not be shorter than previous variants. Dr Marjolein Irwin-Knoester recommends a maximum of 7-day isolation for most cases, striking a balance between virus infectivity and community acceptance.
Outbreaks in Hong Kong's high-rise housing have shown vertical transmission of COVID-19 via drainage stack bioaerosols, which can spread through pipes and enhance by poor ventilation. The omicron variant has contributed to the rapid spread.
The European Society of Clinical Microbiology and Infectious Diseases finds organ donation from COVID-19 patients is safe and does not transmit SARS-CoV-2. Recipients with asymptomatic infections are also now eligible for transplant, but must be triple-vaccinated.
Organ donation from dying COVID-19 patients appears to be safe and does not infect recipients with SARS-CoV-2. The study found all 6 abdominal organs had stable graft function and no unexpected rejection occurred.
Genetic testing of saliva samples has been shown to be more quick and sensitive than nasal swab testing for detecting SARS-CoV-2 virus, with implications for improving public acceptance of COVID-19 testing and reducing healthcare worker risks
Researchers use artificial intelligence to predict algae's potential as a reliable, economic source for biofuel, overcoming challenges of low yield and high harvesting cost. The project aims to transform the bioeconomy by reducing petroleum dependency and alleviating climate change.
Researchers found a human receptor protein detecting amino acids in the same way as bacteria, leading to potential enhancements of GABA-based drugs. This discovery adds to the sparse evidence of commonalities between bacteria and humans in sensing essential components.
A new study found that molds and yeasts are more prevalent in daycare centers than outside environments. The indoor mycobiome is influenced by factors such as building features and child density, suggesting a potential link between fungi and chronic respiratory diseases like asthma and allergies.
The study defines the lung macrophage as a major target of IL-9, which promotes allergic lung inflammation. The researchers found a correlation between IL-9 and the diagnosis of asthma in patients, suggesting a potential therapeutic approach for treatment.
Researchers engineered Azotobacter vinelandii to produce ammonia and excrete it into crop plants, reducing water pollution. This approach could mitigate environmental pollution and provide sustainable solutions for nitrogen management in soil.
Researchers at Uppsala University discovered that the ancestors of Legionella bacteria infected eukaryotic cells around 2 billion years ago. This finding challenges the chicken-or-egg debate about which came first, phagocytosis or mitochondria evolution.
A study found that previous COVID-19 infection improves the performance of antibodies and potentially provides longer-term protection, especially in obese individuals. In contrast, vaccination does not enhance antibody quality and may not provide sustained immunity in those who have been previously infected or overweight.
A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae. Researchers are exploring therapy using lung epithelial stem and progenitor cells to mitigate virus-induced inflammatory storm and promote tissue regeneration efficiently.
Researchers found that compost and compost-enriched soils contain high concentrations of Aspergillus fumigatus spores, which can cause serious lung infections. Handling compost exposes individuals to large numbers of aerosolized spores, highlighting the need for behavioral changes and industry action
A Houston Methodist study found that lifting COVID-19 restrictions led to a rapid return of seasonal respiratory viruses, highlighting the effectiveness of masking and distancing measures. The study's findings demonstrate that these precautions can suppress all respiratory viruses, not just COVID-19.
Researchers found that omitting or altering the buffer solution can generate false positive results, highlighting its essential role in test function. The study's findings have far-reaching implications for public health worldwide, as the rapid antigen test has been distributed to over 120 countries.
Pooled saliva sample COVID-19 testing demonstrated over 95% agreement with the gold standard and detected 83% of semester's cases. The approach is among the most sensitive available, detecting virus at very low viral load, and provides results in under 8 hours.
The study tracks ocean microbes consuming different types of organic carbon produced by phytoplankton species, revealing predictable food source preferences. The findings have implications for understanding marine microbes and photosynthetic algae's impact on global carbon cycling.
The Verrucomicrobiota group of bacteria plays a crucial role in degrading polysaccharides released by algae during spring blooms in the North Sea. These specialized bacteria consume hard-to-degrade sugars, including those containing sulfate and fucose, using unique pathways and organelle-like structures to avoid toxic compounds.
A team from Beth Israel Deaconess Medical Center created all-new swabs for COVID-19 testing in just three weeks by leveraging open-source collaboration and 3D printing. The swab crisis highlighted the importance of cooperation, openness, and scalability in solving complex problems.
Researchers discovered that symbiotic bacteria living in shipworms' gills do not have the enzymes to break down lignin, a thick and difficult-to-digest layer of cellulose. Despite this finding, scientists are still trying to figure out what within the shipworm could be responsible for breaking down lignin.
A recent trial by the European Society of Clinical Microbiology and Infectious Diseases found that azithromycin does not prevent mild COVID-19 cases from progressing to hospitalization or death. The study showed no difference in the risk of progression between those treated with azithromycin and those who received standard care alone.
A study in Switzerland found that people living in poorer neighborhoods were less likely to be tested for COVID-19, but more likely to test positive, be hospitalized, or die compared to those in wealthier areas. The study also found stronger associations between neighborhood socioeconomic position and outcomes in younger age groups.
A new study found that patients taking immunosuppressants like methotrexate had weaker antibody responses to the Pfizer COVID-19 vaccine after the first dose. However, T-cell responses were preserved in these patients, suggesting potential risks and benefits of vaccinating immunocompromised individuals.
The CoronaVac vaccine demonstrated 83.5% protection against symptomatic COVID-19 and 100% effectiveness against hospitalization in a phase 3 trial. The study involved adults aged 18-59 and showed high efficacy with a very good safety profile, but further data is needed on the vaccine's long-term effects and efficacy against new variants.